mRNA |
FH535 |
GDSC1000 |
pan-cancer |
AAC |
0.069 |
0.06 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.062 |
0.06 |
mRNA |
GNF-2 |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.06 |
mRNA |
TG-101348 |
GDSC1000 |
pan-cancer |
AAC |
0.057 |
0.06 |
mRNA |
semagacestat |
CTRPv2 |
pan-cancer |
AAC |
-0.069 |
0.06 |
mRNA |
5-FU |
CTRPv2 |
pan-cancer |
AAC |
-0.063 |
0.06 |
mRNA |
BRD-K30019337 |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.06 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.063 |
0.06 |
mRNA |
tipifarnib |
CTRPv2 |
pan-cancer |
AAC |
-0.058 |
0.06 |
mRNA |
ATRA |
GDSC1000 |
pan-cancer |
AAC |
0.066 |
0.07 |